SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
-11.73%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$374M
AUM Growth
+$374M
(-5.4%)
Cap. Flow
+$57.6M
Cap. Flow
% of AUM
15.41%
Top 10 Holdings %
Top 10 Hldgs %
64.84%
Holding
61
New
5
Increased
7
Reduced
14
Closed
5
Top Buys
| 1 |
Scholar Rock
SRRK
|
$23.4M |
| 2 |
Nkarta
NKTX
|
$10.3M |
| 3 |
Lyra Therapeutics
LYRA
|
$10M |
| 4 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$9.97M |
| 5 |
HilleVax
HLVX
|
$8.34M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$2.43M |
| 2 |
Recursion Pharmaceuticals
RXRX
|
$2.21M |
| 3 |
Aclaris Therapeutics
ACRS
|
$1.37M |
| 4 |
Instil Bio
TIL
|
$941K |
| 5 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$927K |
Sector Composition
| 1 | Healthcare | 97.85% |
| 2 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDNY
1
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $90.3M | 24.07% | 5,161,888 +570,000 | +12% | +$9.97M |
|
|
2
Nkarta
NKTX
$151M
| $35.3M | 9.42% | 2,868,035 +833,333 | +41% | +$10.3M |
|
|
3
Scholar Rock
SRRK
$3.14B
| $25.2M | 6.73% | 4,598,828 +4,259,217 | +1,254% | +$23.4M |
|
|
LENZ
4
LENZ Therapeutics
LENZ
$1.1B
| $23.3M | 6.2% | 8,459,314 +386,711 | +5% | +$1.06M |
|
5
Arcellx
ACLX
$3.85B
| $19.2M | 5.13% | 1,063,835 +64,108 | +6% | +$1.16M |
|
|
FMTX
6
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $10.8M | 2.88% | 1,565,526 | – | – |
|
|
7
Lyra Therapeutics
LYRA
$11.5M
| $10M | 2.68% | +1,777,251 | New | +$10M |
|
|
8
Aclaris Therapeutics
ACRS
$209M
| $9.72M | 2.59% | 696,171 -98,000 | -12% | -$1.37M |
|
|
ISEE
9
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $9.72M | 2.59% | 1,010,051 -252,500 | -20% | -$2.43M |
|
|
ICPT
10
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $8.85M | 2.36% | 640,688 | – | – |
|
11
Sutro Biopharma
STRO
$72.7M
| $8.73M | 2.33% | 1,675,579 | – | – |
|
|
RAIN
12
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $8.68M | 2.31% | 1,560,652 -10,727 | -0.7% | -$59.6K |
|
|
13
HilleVax
HLVX
$105M
| $8.34M | 2.22% | +762,577 | New | +$8.34M |
|
|
14
Instil Bio
TIL
$182M
| $8.26M | 2.2% | 1,788,280 -203,670 | -10% | -$941K |
|
|
CNTA
15
Centessa Pharmaceuticals
CNTA
$2.25B
| $8.25M | 2.2% | 1,693,736 -190,360 | -10% | -$927K |
|
16
PepGen
PEPG
$38M
| $6.47M | 1.72% | +651,050 | New | +$6.47M |
|
17
Immunocore
IMCR
$1.62B
| $6.01M | 1.6% | 160,963 | – | – |
|
18
Zymeworks
ZYME
$1.12B
| $5.15M | 1.37% | 970,987 | – | – |
|
|
JYAC
19
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
| $5.01M | 1.34% | 507,041 | – | – |
|
20
IO Biotech
IOBT
$104M
| $4.71M | 1.26% | 1,008,437 -112,000 | -10% | -$523K |
|
|
VRNA
21
Verona Pharma
VRNA
$9.16B
| $4.66M | 1.24% | 1,111,112 | – | – |
|
22
Janux Therapeutics
JANX
$1.37B
| $4.4M | 1.17% | 360,414 -51,457 | -12% | -$628K |
|
|
DICE
23
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $3.93M | 1.05% | 253,466 +25,000 | +11% | +$388K |
|
24
EyePoint Pharmaceuticals
EYPT
$797M
| $3.78M | 1.01% | 480,000 | – | – |
|
25
Day One Biopharmaceuticals
DAWN
$769M
| $3.52M | 0.94% | 196,425 -6,075 | -3% | -$109K |
|